GEP20002244B - Osteoprotegerin - Google Patents
OsteoprotegerinInfo
- Publication number
- GEP20002244B GEP20002244B GEAP19963840A GEAP1996003840A GEP20002244B GE P20002244 B GEP20002244 B GE P20002244B GE AP19963840 A GEAP19963840 A GE AP19963840A GE AP1996003840 A GEAP1996003840 A GE AP1996003840A GE P20002244 B GEP20002244 B GE P20002244B
- Authority
- GE
- Georgia
- Prior art keywords
- opg
- bone diseases
- osteoprotegerin
- disclosed
- treatment
- Prior art date
Links
- 102000008108 Osteoprotegerin Human genes 0.000 title 1
- 108010035042 Osteoprotegerin Proteins 0.000 title 1
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 title 1
- 208000020084 Bone disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Technical Result Increase in treatment efficiency of bone diseases. 2. Essence Disclosed is a new member of the tumor-osteoprotegerin (OPG) necrosis factor receptor superfamily. Also disclosed are nucleic acids encoding OPG, polypeptides, recombinant vectors and host cells for OPG expression, antibodies which bind OPG, and pharmaceutical compositions. The method for treatment of bone diseases are developed. 3. Field of Application Medicine, therapy. Figures: 28
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70694595A | 1995-12-22 | 1995-12-22 | |
| US08/577,788 US6613544B1 (en) | 1995-12-22 | 1995-12-22 | Osteoprotegerin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20002244B true GEP20002244B (en) | 2000-09-25 |
Family
ID=82493846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP19963840A GEP20002244B (en) | 1995-12-22 | 1996-12-20 | Osteoprotegerin |
Country Status (1)
| Country | Link |
|---|---|
| GE (1) | GEP20002244B (en) |
-
1996
- 1996-12-20 GE GEAP19963840A patent/GEP20002244B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9706193A (en) | Osteoprotegerin. | |
| AU779461C (en) | Osteoprotegerin binding proteins and receptors | |
| AU7953194A (en) | Calcitonin receptor | |
| PL314051A1 (en) | Recombined obesity proteins (ob), fusion proteins, expression vectors, sequential dnas, transformed e, collie cells, method of obtaining recombined human or mouse's obesity protein and pharmaceutic composition | |
| HRP980203B1 (en) | Modified tnf "alpha" molecules, dna encoding such modified tnf "alpha" molecules and vaccines comprising such modified tnf "alpha" molecules and dna | |
| NO913211L (en) | NEW MONOCLONAL ANTIBODY AGAINST NEW ANTIGEN ANNOUNCED TO HUMAN TUMORS. | |
| GEP20033002B (en) | Osteoprotegerin Binding Protein and Receptors | |
| HU9600692D0 (en) | Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds | |
| AU1724795A (en) | Human tissue inhibitor of metalloproteinase-4 | |
| NZ508381A (en) | Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5) | |
| IL105554A0 (en) | Peptides of human papilloma virus for use in human t cell response inducing compositions | |
| NZ223506A (en) | Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions | |
| WO1995030003A3 (en) | Morphogenic protein-specific cell surface receptors and uses therefor | |
| HUP9902429A2 (en) | Modulators of tnf receptor associated factor (traf), their preparation and use | |
| WO2001003719A3 (en) | Combination therapy for conditions leading to bone loss | |
| AU9291198A (en) | Apoptosis-related compounds and their use | |
| BR9710975A (en) | Genes of 120 kda exposed surface adhesion protein immunodominant of ehrlichia chaffeensis | |
| NZ333203A (en) | Tumour antigen proteins, genes thereof, and tumour antigen peptides | |
| EP1655382A3 (en) | Colon specific gene and protein | |
| GEP20043386B (en) | β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same | |
| AU3390995A (en) | Novel implant and novel vector for the treatment of acquired diseases | |
| SG128403A1 (en) | Tnf-receptors, tnf binding proteins and dnas coding for them | |
| DE69332583D1 (en) | MASPIN- A NEW SERPIN WITH TUMOR REPRESSIVE ACTIVITY | |
| WO2002000822A3 (en) | A NOVEL POLYPEPTIDE, A HUMAIN PROTEIN SYNTHESIS INITIATION FACTOR SUB-UNIT 2 β 16.5 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE | |
| MX9709390A (en) | Human cystatin e. |